This was released today, but did not seem to have as much of an impact as some of the past articles.
HENDERSON, NV / ACCESSWIRE / October 17, 2018 / Below are a few opportunities to help with one of America's largest problems: opioid addiction. While cannabis stocks have been receiving a lot of the attention due to the healing properties of CBD.While there are certainly intriguing options, it's important to not overlook that there is still some Federal gridlock over rules regarding the drug.
There are several non-CBD options that look promising, including Endonovo Therapeutics, Inc. (ENDV)'s non-invasive pain reduction treatment, SofPulse, which could render troublesome opioid prescriptions irrelevant. (ENDV).This 5-cent stock has received price targets from research firms as high as 25 cents a share.
ENDV is sure to receive plenty of attention as their technology develops and would be a wise company for investors looking to diversify in non-opiod pain management option.
Companies to focus on include:Endonovo Therapeutics, Inc. (ENDV), Aphria, Inc.(APHQF), OrganiGram Holdings, Inc. (ORMGF), Auxly Cannabis Group, Inc. (CBWTF), and Aleafia Health, Inc. (ALEAF).
Endonovo Therapeutics, Inc. (ENDV)
Market Cap: $16.35M Share Price: $0.043
Endonovo Therapeutics, Inc. (ENDV), a commercial-stage developer of Electroceutical™ Therapies, announced a distribution agreement with Magniant, LLC for the distribution of Sofpulse, its non-invasive Electroceutical™ Therapy for post-operative pain relief and reduction of swelling. The agreement with Magniant includes sales, marketing and distribution targeting the VA, DOD, Indian Health Services, Long Term Care Institutions, Pain Clinics, Wound Clinics and Private Practices among physicians.
Alan Collier, Endonovo Chief Executive Officer, stated, "We are thrilled to partner with Magniant, an established firm with significant health industry experience, in depth knowledge of product launches and, more importantly, relationships with healthcare professionals and facilities throughout the United States.In addition to a professional, accountable team of commission-based representatives, Magniant delivers meaningful senior leadership in the areas of Supply Chain, FP&A, Operations and Logistics, Marketing, and Clinical Business Development.I welcome the opportunity of working with their team and expanding our Sofpulse device on a national level."
